Exercise
Behavioralsubjects will participate in one of two forms of exercise
NCT Number: NCT01219647
Many persons with Multiple Sclerosis ( MS) have problems with memory and thinking.Exercise has been shown to improve memory and thinking in persons with diseases such as Alzheimer's. This study will investigate whether a program of aerobic exercise can improve memory and thinking in persons with MS
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 1 / Phase 2
UCalifornia at Los Angeles, Los Angeles, California, United States
Persons with Multiple Sclerosis(MS)will be screened for eligibility and randomized to a protocol with two intervention arms. One group will have aerobic training on a recumbent cross trainer three times a week for 20-30 minutes/session. The other group will participate in stretching exercises at the same frequency and intensity.Total training time will be six months.Outcome measures will include tests of memory and thinking, and fitness measures.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
subjects will participate in one of two forms of exercise
subjects will particiopate in supervised stretching as described in arm description.
Time frame: 36 weeks
test of attention and information processing
Time frame: 36 weeks
test of attention and information processing
Time frame: 36 weeks
measure of fitness via oxygen consumption and use
Time frame: 36 weeks
electrophysiologic tests of information processing
University of California, Los Angeles
Other
Acronym: CogEx
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07543900
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Vigo, Pontevedra, Spain
View Trial DetailsNCT06871072
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Seville, Spain
View Trial DetailsNCT05951985
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Fort Smith, Arkansas, United States
View Trial DetailsNCT07118514
Anxiety Disorders, Autoimmune Diseases
Maringá, Paraná, Brazil
View Trial Details